ACKERMANS & VAN HAAREN NV

Official Publications Ackermans & van Haaren NV London S.E.

Equities

0GYM

BE0003764785

Real-time Estimate Tradegate Other stock markets 14:16:44 03/07/2024 BST			5-day change	1st Jan Change
166.4 ^EUR	+2.02%		+0.88%	+4.34%

06-24	Vico Therapeutics B.V. announced that it has received ?65.8 million in funding from a group of investors	CI
06-17	STAR Capital Partnership LLP, Ackermans & Van Haaren NV and and others Investors entered into an agreement to acquire Vouvray Acquisition Limited from Advent International, L.P.	CI

Official Publications

Annual results	27/02/23	CO
Share buyback	15/01/23	CO
Slide show Q3	22/11/22	CO
3rd quarter results	22/11/22	CO
3rd quarter results	22/11/22	CO
3rd quarter results	22/11/22	CO
Share buyback	01/11/22	CO
Share buyback	01/11/22	CO
Share buyback	01/11/22	CO
Share buyback	23/10/22	CO
Share buyback	23/10/22	CO
Share buyback	23/10/22	CO
Share buyback	12/10/22	CO
Share buyback	12/10/22	CO
Share buyback	12/10/22	CO
Share buyback	03/10/22	CO
Share buyback	03/10/22	CO
Share buyback	03/10/22	CO
1st-half-year results	30/08/22	CO
1st-half-year results	30/08/22	CO
1st-half-year results	30/08/22	CO
Slide show half-year results	30/08/22	CO
Half-year report	30/08/22	CO
Half-year report	30/08/22	CO
Half-year report	30/08/22	CO

5 6 7 8

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Headlines

Ackermans & van Haaren: Q1-24

ACKERMANS & VAN HAAREN : Q1-24: Ackermans off to a solid start

May 23, 2024 at 05:48 pm

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer